Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Thrombotic and Bleeding Events”

13 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 13 of 13 results

Early research (Phase 1)UnknownNCT04741139
What this trial is testing

Post IVIG Medication in Children With Immune Thrombocytopenia

Who this might be right for
Immune Thrombocytopenia
Baylor College of Medicine 20
Not applicableNot Yet RecruitingNCT07405749
What this trial is testing

Cirrhotic and Non-cirrhotic Patients With Clinically Significant Portal Hypertension

Who this might be right for
Cirrhosis, LiverPortal HypertensionClinically Significant Portal Hypertension(CSPH)+1 more
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 2,500
Not applicableStudy completedNCT03120182
What this trial is testing

Chronic Subdural Hematoma and Aspirin

Who this might be right for
Chronic Subdural Hematoma
University Hospital, Basel, Switzerland 150
Early research (Phase 1)Study completedNCT07312851
What this trial is testing

Investigate Andexanet Dosing and the Interaction Between Andexanet and Subsequent Enoxaparin in Healthy Participants

Who this might be right for
Healthy Participants
AstraZeneca 191
Large-scale testing (Phase 3)Study completedNCT04569279
What this trial is testing

Rivaroxaban vs. Warfarin in CVT Treatment

Who this might be right for
Cerebral Vein Thrombosis
Damascus University 71
Not applicableNot Yet RecruitingNCT06884384
What this trial is testing

DOAC Versus VKA in Patients With Non-high-risk APS : Prospective Cohort Study

Who this might be right for
Antiphospholipid Syndrome (APS)Cohort StudyThrombotic and Bleeding Events
Central Hospital, Nancy, France 310
Not applicableStudy completedNCT00753753
What this trial is testing

VerifyNow French Registry

Who this might be right for
Stent ThrombosisClopidogrelAspirin+2 more
Association Pour le Développement des Soins Cardiologiques de la ville de Chartres 1,001
Not applicableEnded earlyNCT01938404
What this trial is testing

Octaplas Adult TTP Trial

Who this might be right for
Thrombotic Thrombocytopenic Purpura
Octapharma 1
Not applicableActive Not RecruitingNCT02677974
What this trial is testing

On-X Aortic Prosthetic Heart Valve Low Dose Warfarin Post Approval Clinical Registry Study

Who this might be right for
Thrombotic and Bleeding Events
On-X Life Technologies, Inc. 510
Not applicableLooking for participantsNCT06868823
What this trial is testing

Prospective Observational Pilot Study of LMWH Versus UFH as ECMO Anticoagulation in Lung Transplantation

Who this might be right for
Lung TransplantationExtracorporeal Membrane Oxygenation (ECMO)Anticoagulants and Bleeding Disorders
University Hospital, Motol 40
Large-scale testing (Phase 3)Study completedNCT04188379
What this trial is testing

Assess the Efficacy and Safety of Efgartigimod in Adult Patients With Primary Immune Thrombocytopenia (ITP).

Who this might be right for
Primary Immune Thrombocytopenia
argenx 131
Large-scale testing (Phase 3)Active Not RecruitingNCT00319228
What this trial is testing

Safety, Pharmacokinetics and Efficacy of an ATIII Concentrate

Who this might be right for
Antithrombin III Deficiency
Grifols Biologicals, LLC 30
Not applicableNot Yet RecruitingNCT06929182
What this trial is testing

OBServaToIre interNational Des Patients AnTiphospholipidEs traités Par Anticoagulants Oraux Directs

Who this might be right for
Antiphospholipid Syndrome (APS)Direct Oral Anticoagulants (DOACs)Thrombotic and Bleeding Events+1 more
Central Hospital, Nancy, France 500